Compare AKBA & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | JACK |
|---|---|---|
| Founded | 2007 | 1951 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.0M | 258.3M |
| IPO Year | 2014 | 1994 |
| Metric | AKBA | JACK |
|---|---|---|
| Price | $1.22 | $14.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 14 |
| Target Price | $4.67 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 4.1M | 1.2M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.94 | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | ★ $1,465,314,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.04 |
| P/E Ratio | ★ N/A | $34.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $8.92 |
| 52 Week High | $3.81 | $23.91 |
| Indicator | AKBA | JACK |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 49.71 |
| Support Level | $1.16 | $14.22 |
| Resistance Level | $1.52 | $20.84 |
| Average True Range (ATR) | 0.07 | 1.06 |
| MACD | -0.02 | -0.26 |
| Stochastic Oscillator | 7.59 | 35.96 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.